Page 6 - Syncona Ltd News Today

Plasmid CDMO alliance supports first gene therapy platform targeting kidney diseasesWILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) and Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announced a...

Investegate announcements from Syncona Limited, Autolus announces partial exercise of ADS option

Autolus announces pricing of public offeringSyncona Ltd, a leading healthcare company focused on creating, building and scaling global leaders in life science, notes that its portfolio company, Autolus Therapeutics plc ("Autolus") today announced the pricing of its underwritten public offering in the United States o...

Investegate announcements from Syncona Limited, Autolus announces pricing of public offering

Autolus announces FELIX trial of obe-cel meets its primary endpoint09 December 2022Syncona Ltd, a leading healthcare company focused on creating, building and scaling global leaders in life science, notes that its portfolio company, Autolus Therapeutics Plc (Nasdaq: AUTL) (“Autolus”), has announced that...

Investegate announcements from Syncona Limited, Achilles to present clinical data update

Investegate announcements from Syncona Limited, Neogene to be acquired by AstraZeneca

Investegate announcements from Syncona Limited, Freeline reports Q3 2022 Financial Results

Investegate announcements from Syncona Limited, Anaveon presents updated data from ANV419

Investegate announcements from Syncona Limited, Achilles reports Q3 2022 Financial Results